Zimmer Biomet (NYSE:ZBH – Get Free Report)‘s stock had its “hold” rating reaffirmed by stock analysts at Needham & Company LLC in a research note issued to investors on Wednesday,Benzinga reports.
Zimmer Biomet Holdings Inc (NYSE:ZBH), a leading player in the medical devices sector with a market capitalization of $22.12 ...
BTIG analyst Ryan Zimmerman has maintained their bullish stance on ZBH stock, giving a Buy rating on January 23.Invest with Confidence: Follow ...
Inc. has announced Tuesday evening plans to acquire Paragon 28, Inc. (Paragon 28), a move that Moody's (NYSE:MCO) Ratings ...
Zimmer Biomet made a major play in the foot and ankle treatment space today, announcing it will spend $1.2 billion to acquire ...
In a report released today, Caitlin Cronin from Canaccord Genuity maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report), ...
Paragon 28, Inc. (NYSE:FNA) shares are trading higher premarket on Wednesday. On Tuesday, the company inked a deal to be ...
Fifth Third Bancorp lessened its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 2.5% in the fourth ...
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products ...
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Paragon 28, Inc. (NYSE: FNA), a leading medical device company focused exclusively on the foot and ankle ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...